Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled... by Neogi, Tuhina, Hunter, David J, Churchill, Melvin, Shirinsky, Ivan, White, Alexander, Guermazi, Ali, Omata, Masanari, Fountaine, Robert J, Pixton, Glenn, Viktrup, Lars, Brown, Mark T, West, Christine R, Verburg, Kenneth M

Get full text

A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rhe... by Martin, David A, Churchill, Melvin, Flores-Suarez, Luis, Cardiel, Mario H, Wallace, Daniel, Martin, Richard, Phillips, Kristine, Kaine, Jeffrey L, Dong, Hua, Salinger, David, Stevens, Erin, Russell, Chris B, Chung, James B

Get full text

A randomized clinical trial to evaluate two doses of an intra-articular injection of LMWF-5A in adults with pain due to osteoarthritis of the knee by Bar-Or, David, Salottolo, Kristin M, Loose, Holli, Phillips, Matthew J, McGrath, Brian, Wei, Nathan, Borders, James L, Ervin, John E, Kivitz, Alan, Hermann, Mark, Shlotzhauer, Tammi, Churchill, Melvin, Slappey, Donald, Clift, Vaughan

Get full text

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseas... by van der Heijde, Désirée, Cheng-Chung Wei, James, Dougados, Maxime, Mease, Philip, Deodhar, Atul, Maksymowych, Walter P, Van den Bosch, Filip, Sieper, Joachim, Tomita, Tetsuya, Landewé, Robert, Zhao, Fangyi, Krishnan, Eswar, Adams, David H., Pangallo, Beth, Carlier, Hilde, Churchill, Melvin, Flint, Kathleen, Gladstein, Geoffrey, Greenwald, Maria, Howell, Mary, Ince, Akgun, Kaine, Jeffrey, Mehta, Daksha, Peters, Eric, Querubin, Roel, Reveille, John, Roseff, Richard, Diegel, Roger, Thai, Christine, Bessette, Louis, Morin, Frederic, Rahman, Proton, Barrera Rodriguez, Aaron Alejandro, Cons-Molina, Fidencio, Duran Barragan, Sergio, Skinner, Cassandra, Pacheco Tena, Cesar, Ramos Remus, Cesar, Rizo Rodriguez, Juan Cruz, Hong, Seung-Jae, Lee, Yeon-Ah, Ju, Ji Hyeon, Kang, Seong Wook, Kim, Tae-Hwan, Lee, Chang Keun, Lee, Eun Bong, Lee, Sang Heon, Park, Min-Chan, Shin, Kichul, Lee, Sang-Hoon, Chen, Hung-An, Chen, Ying-Chou, Hsieh, Song-Chou, Lan, Joung-Liang, Dvorak, Zdenek, Moravcova, Radka, Malcova, Martina, Taniguchi, Yoshinori, Kishimoto, Mitsumasa, Tada, Kurisu, Dobashi, Hiroaki, Inui, Kentaro, Ueki, Yukitaka, Matsumoto, Yoshifuji, Koyama, Yoshinobu, Hatta, Kazuhiro, Atsumi, Tatsuya, Goto, Hitoshi, Matsui, Kiyoshi, Takakubo, Yuya, Neeck, Gunther, Poddubnyy, Denis, Rubbert-Roth, Andrea, Szymanska, Malgorzata, Blicharski, Tomasz, Dudek, Anna, Racewicz, Artur, Wojciechowski, Rafal, van de Sande, Marleen, Griep, Ed, Nurmohamed, Mike, Matsievskaya, Galina, Shmidt, Evgeniya, Stanislav, Marina, Yakushin, Sergey, Ershova, Olga, Rebrov, Andrey, Balazs, Tibor, Cseuz, Regina, Drescher, Edit, Poor, Gyula

Get full text

Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, doubl... by Nash, Peter, Prof, Kirkham, Bruce, Prof, Okada, Masato, MD, Rahman, Proton, Prof, Combe, Benard, Prof, Burmester, Gerd-Ruediger, Prof, Adams, David H, PhD, Kerr, Lisa, MSPH, Lee, Chin, MD, Shuler, Catherine L, MS, Genovese, Mark, Prof

Get full text

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial by Deodhar, Atul, van der Heijde, Désirée, Gensler, Lianne S, Kim, Tae-Hwan, Maksymowych, Walter P, Østergaard, Mikkel, Poddubnyy, Denis, Marzo-Ortega, Helena, Bessette, Louis, Leung, Ann, Hojnik, Maja, Gallo, Gaia, Li, Xiaoqi, Carlier, Hilde, Sieper, Joachim, Morin, Frederic, Rahman, Proton, Ariel, Federico, Berman, Alberto, Carrio, Judith, Lucero, Eleonora, Cocco, Jose Maldonado, Viola, Diego O., Grisar, Johannes, Resch, Heinrich, Scheinecker, Clemens, Melazzi, Ana Claudia, Roimicher, Luis, Rodriguez, Aaron Alejandro Barrera, Molina, Francisco Fidencio Cons, Barragan, Sergio Duran, Skinner, Cassandra M., Tena, Cesar Francisco Pacheco, Remus, Cesar Ricardo Ramos, Rodriguez, Juan Cruz Rizo, Hong, Seung-Jae, Kang, Seong Wook, Lee, Chang Keun, Lee, Sang Heon, Park, Min-Chan, Lee, Sang-Hoon, Dokoupilova, Eva, Dvorak, Zdenek, Malcova, Martina, Pvelka, Karel, Eklund, Kari K., Jarvinen, Pentti, Paimela, Leena, Taniguchi, Yoshinori, Tsuda, Tokutaro, Tada, Kurisu, Dobashi, Hiroaki, Inui, Kentaro, Ueki, Yukitaka, Matsumoto, Yoshifuji, Hatta, Kazuhiro, Atsumi, Tatsuya, Goto, Hitoshi, Matsui, Kiyoshi, Takakubo, Yuya, Neeck, Gunther, Blicharshi, Tomasz, Dudek, Anna, Hrycai, Pawel, Plebanski, Rafal, Drabiszcak-Piatkowska, Janina, Brzezicki, Jan, Krogulec, Marek, Opris-Belinski, Daniela, Ramazan, Ana Maria, Tronaru, Luminita, van de Sande, Marleen G., Matsievskaya, Galina, Stanislav, Marina, Yakushin, Sergey, Ershova, Olga, Rebroy, Andrey, Churchill, Melvin A., Flint, Kathleen P., Greenwald, Maria, Howell, Mary P., Kivitz, Alan, Klein, Steven J., Mueller, Eric C., Peters, Eric A., Querubin, Roel, Sayers, Michael E., Scoville, Craig D., Shanahan, Joseph C., Hull, John E., Sebai, Mohamed B., Kimmel, Steven C., Goddard, David H., Harris, Mark D., Mabaquiao, Arthur R., Diegel, Roger J., Thai, Christine, Rivera, Tania L., Perez-De Jesus, Amarilis, Pantojas, Carlos

Get full text

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial by Gabay, Cem, MD, Emery, Paul, MD, van Vollenhoven, Ronald, MD, Dikranian, Ara, MD, Alten, Rieke, MD, Pavelka, Karel, MD, Klearman, Micki, MD, Musselman, David, MD, Agarwal, Sunil, MD, Green, Jennifer, MSc, Kavanaugh, Arthur, Dr

Get full text

Secukinumab in United States Biologic-Naïve Patients With Psoriatic Arthritis: Results From the Randomized, Placebo-Controlled CHOICE Study by Nguyen, Tien, Churchill, Melvin, Levin, Robert, Valenzuela, Guillermo, Merola, Joseph F, Ogdie, Alexis, Orbai, Ana-Maria, Scher, Jose U, Kavanaugh, Arthur, Kianifard, Farid, Rollins, Chauncy, Calheiros, Renato, Chambenoit, Olivier

Get full text

A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol by Curtis, Jeffrey R., Churchill, Melvin, Kivitz, Alan, Samad, Ahmed, Gauer, Laura, Gervitz, Leon, Koetse, Willem, Melin, Jeffrey, Yazici, Yusuf

Get full text

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate‐Naive Patients With Rheumatoid Arthritis: Five‐Year Results of a Randomized Clinical Trial by Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo, Han, Chenglong, Gathany, Timothy A., Xu, Stephen, Zhou, Yiying, Leu, Jocelyn H., Hsia, Elizabeth C.

Get full text

Golimumab, a Human Anti–Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexa... by Emery, Paul, Fleischmann, Roy M., Doyle, Mittie K., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric, Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo, Xu, Weichun, Xu, Stephen, Wu, Zhong, Hsia, Elizabeth C.

Get full text

97. Final 5-Year Safety and Efficacy Results of a Phase 3, Randomized, Placebo-Controlled Trial of Golimumab in Methotrexate-NaïVe Patients with Rheumatoid Arthritis by Emery, Paul, Fleischmann, Roy M., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric, Churchill, Melvin, Park, W., Pons-Estel, Bernardo, Han, Chenglong, Gathany, Tim, Zhou, Yiying, Xu, Stephen, Hsia, Elizabeth C.

Get full text

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthritis: Twent... by Emery, Paul, Fleischmann, Roy M., Moreland, Larry W., Hsia, Elizabeth C., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo Antonio, Doyle, Mittie K., Visvanathan, Sudha, Xu, Weichun, Rahman, Mahboob U.

Get full text

Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: Results of a two‐year, random... by O'Dell, James R., Leff, Robert, Paulsen, Gail, Haire, Claire, Mallek, Jack, Eckhoff, P. James, Fernandez, Ana, Blakely, Kent, Wees, Steven, Stoner, Julie, Hadley, Stephen, Felt, Jeffrey, Palmer, William, Waytz, Paul, Churchill, Melvin, Klassen, Lynell, Moore, Gerald

Get full text

Erratum: Golimumab, a human anti‐tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate‐naive patients with active rheumatoid arthrit... by Emery, Paul, Fleischmann, Roy M., Moreland, Larry W., Hsia, Elizabeth C., Strusberg, Ingrid, Durez, Patrick, Nash, Peter, Amante, Eric Jason B., Churchill, Melvin, Park, Won, Pons‐Estel, Bernardo Antonio, Doyle, Mittie K., Visvanathan, Sudha, Xu, Weichun, Rahman, Mahboob U.

Get full text

Treatment of early seropositive rheumatoid arthritis with minocycline: Four‐year followup of a double‐blind, placebo‐controlled trial by O'Dell, James R., Paulsen, Gail, Haire, Claire E., Blakely, Kent, Palmer, William, Wees, Steven, Eckhoff, P. James, Klassen, Lynell W., Churchill, Melvin, Doud, Deborah, Weaver, Arthur, Moore, Gerald F.

Get full text

Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trial by O'Dell, James R., Haire, Claire E., Palmer, William, Drymalski, Walter, Wees, Steven, Blakely, Kent, Churchill, Melvin, Eckhoff, P. James, Weaver, Arthur, Doud, Deborah, Erikson, Nils, Dietz, Fred, Olson, Rich, Maloley, Pierre, Klassen, Lynell W., Moore, Gerald F.

Get full text

Correction. The Crystal Structure of Bis(imidotetramethyldithiodiphosphino-S,S)nickel(II) a Tetrahedral Complex with an NiS4 core by Churchill, Melvin, Cooke, Joan, Fennessey, James, Wormald, John

Get full text

The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins by Melvin, Vida Senkus, Roemer, Sarah C., Churchill, Mair E.A., Edwards, Dean P.

Get full text

The Role of the C-terminal Extension (CTE) of the Estrogen Receptor α and β DNA Binding Domain in DNA Binding and Interaction with HMGB by Melvin, Vida Senkus, Harrell, Chuck, Adelman, James S., Kraus, W. Lee, Churchill, Mair, Edwards, Dean P.

Get full text